Empower Sermorelin is a compounded GHRH analog. Discover how it works, its legal status, typical dosing, and how it compares to other growth hormone peptides.
Empower Sermorelin is a compounded version of sermorelin, a growth hormone-releasing hormone (GHRH) analog, made by Empower Pharmacy. It is not an FDA-approved drug for human use, but it can be legally prescribed and dispensed by licensed compounding pharmacies in the United States. This article explains what Empower Sermorelin is, how it works, and what to consider before using it.
What Is Sermorelin and How Does It Work?
Sermorelin is a synthetic peptide that mimics the first 29 amino acids of naturally occurring GHRH. It stimulates the pituitary gland to produce and release growth hormone (GH). Unlike exogenous GH injections, sermorelin works upstream by signaling the body’s own GH production.
Because it acts on the pituitary, sermorelin may help preserve the natural feedback loop that regulates GH levels. This is different from directly injecting GH, which can suppress the body’s own production. However, sermorelin is not approved by the FDA for any human use, and its risks and benefits are not fully established.
Empower Pharmacy and Compounded Sermorelin
Empower Pharmacy is a large compounding pharmacy based in Houston, Texas. It holds licenses in multiple states and compounds a range of medications, including peptides like sermorelin. Compounded drugs are not FDA-approved, but they can be legally prepared by a licensed pharmacist with a valid prescription.
Empower Sermorelin is typically sold as a lyophilized powder that must be reconstituted with bacteriostatic water before injection. Compounded medications are not reviewed by the FDA for safety, effectiveness, or quality. The purity and potency of Empower Sermorelin can vary, so you should only use products from a reputable compounding pharmacy and under medical supervision.
Legal and Regulatory Status in the US
Sermorelin is not FDA-approved for human use in the United States. The original brand-name product, Geref, was discontinued. Today, sermorelin is available only as a compounded medication, which means it is prepared by a compounding pharmacy based on a doctor’s prescription.
Compounded sermorelin is legal under federal law, but its use is considered off-label. The FDA does not evaluate compounded drugs for safety or efficacy. Some states have additional restrictions on compounding certain peptides.
Because of these regulatory gaps, you should only obtain Empower Sermorelin through a licensed telehealth or in-person provider who can monitor your treatment. Self-medicating with peptides bought online is risky and may be illegal.
Common Uses and Off-Label Purposes
People seek Empower Sermorelin for several off-label reasons. The most common is to increase growth hormone levels, which some believe can improve body composition, energy, and recovery. However, these benefits are not proven by large clinical trials.
Other reported uses include:
- Anti-aging and longevity protocols
- Fat loss and muscle growth support
- Improved sleep quality
- Recovery from injury or intense exercise
None of these uses are FDA-approved, and the evidence for most of them is limited. Sermorelin is not a cure for any disease, and it should not replace proven treatments.
Dosing and Administration
Sermorelin is usually injected subcutaneously, often at night to mimic the body’s natural GH pulse. Typical compounded doses range from 100 mcg to 300 mcg per day, but dosing is highly individual and must be set by a healthcare provider.
For those comparing options, sermorelin ipamorelin cjc1295 dosage protocols often combine multiple peptides to amplify effects. However, stacking peptides increases the risk of side effects and is not supported by robust clinical data.
The table below compares common growth hormone–related peptides, including how they are typically dosed and their regulatory status.
| Peptide | Mechanism | Typical Compounded Dose | FDA Status |
|---|---|---|---|
| Sermorelin | GHRH analog | 100–300 mcg daily | Not approved |
| Tesamorelin | GHRH analog | 1–2 mg daily | Approved for HIV lipodystrophy |
| CJC-1295 | GHRH analog | 1–2 mcg/kg weekly | Not approved |
| Ipamorelin | Ghrelin mimetic | 200–300 mcg daily | Not approved |
Safety, Side Effects, and Risks
Sermorelin is generally considered to have a favorable safety profile compared to direct GH injections. Common side effects may include injection-site reactions, headache, flushing, and dizziness. More serious risks are rare but can include changes in blood sugar, fluid retention, and pituitary effects.
Because sermorelin stimulates GH release, it could theoretically worsen conditions sensitive to growth hormone, such as diabetes or certain cancers. People with a history of cancer, pituitary disease, or diabetes should avoid sermorelin unless cleared by a doctor.
Long-term safety data for compounded sermorelin are lacking. The FDA has not approved sermorelin for any indication, so all use is off-label and experimental. You should discuss all risks with a licensed healthcare professional before starting treatment.
How Empower Sermorelin Compares to Other Peptides
When researching options, many people compare sermorelin vs tesamorelin. Tesamorelin is FDA-approved for HIV-associated lipodystrophy, while sermorelin is only available as a compounded product. Tesamorelin may be more potent for visceral fat loss, but it is also more expensive and requires a prescription for a specific condition.
Another common comparison is tesamorelin vs sermorelin vs cjc-1295. All three are GHRH analogs, but they differ in half-life, potency, and approval status. CJC-1295 has a longer half-life and is often used in research settings, while sermorelin is shorter-acting.
Some users combine sermorelin cjc-1295 to try to extend GH release, but this combination is not FDA-approved and lacks clinical evidence. Similarly, lipo-c empower is a compounded injection sometimes marketed for fat loss, but it contains different ingredients and is not a substitute for sermorelin.
Always consult a qualified provider before combining peptides or using any compounded product.
Frequently Asked Questions
Is Empower Sermorelin FDA-approved?
No. Sermorelin is not FDA-approved for human use in the United States. Empower Pharmacy compounds it as a prescription medication, but compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality.
What is the typical dosage of Empower Sermorelin?
Typical compounded doses range from 100 mcg to 300 mcg per day, usually injected subcutaneously at night. However, dosing must be individualized by a healthcare provider, and there is no standard FDA-approved dose.
How does Empower Sermorelin compare to tesamorelin?
Tesamorelin is FDA-approved for HIV-associated lipodystrophy, while sermorelin is only available as a compounded product. Tesamorelin may be more potent for visceral fat loss, but it is more expensive and requires a prescription for a specific condition.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.